Found: 32
Select item for more details and to access through your institution.
Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 386, doi. 10.1111/bjh.17334
- By:
- Publication type:
- Article
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long‐term cognitive functioning.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 5, p. e304, doi. 10.1111/bjh.16877
- By:
- Publication type:
- Article
The COVID‐19 pandemic and management of GIMEMA clinical trials: changes and challenges.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 4, p. e211, doi. 10.1111/bjh.16996
- By:
- Publication type:
- Article
Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 642, doi. 10.1111/bjh.15251
- By:
- Publication type:
- Article
Prognostic impact of KMT2A‐AFF1‐positivity in 926 BCR‐ABL1‐negative B‐lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E334, doi. 10.1002/ajh.26253
- By:
- Publication type:
- Article
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 292, doi. 10.1002/ajh.26066
- By:
- Publication type:
- Article
IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040934
- By:
- Publication type:
- Article
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- Published in:
- Annals of Hematology, 2015, v. 94, n. 1, p. 23, doi. 10.1007/s00277-014-2177-y
- By:
- Publication type:
- Article
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals?
- Published in:
- Annals of Hematology, 2012, v. 91, n. 9, p. 1371, doi. 10.1007/s00277-012-1458-6
- By:
- Publication type:
- Article
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 825, doi. 10.1007/s00277-012-1436-z
- By:
- Publication type:
- Article
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 6979, doi. 10.3390/jcm11236979
- By:
- Publication type:
- Article
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3334, doi. 10.3390/cancers12113334
- By:
- Publication type:
- Article
Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion‐dependent patients with myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 5, p. 442, doi. 10.1111/ejh.13222
- By:
- Publication type:
- Article
Asking patients with hematological malignancies: ‘how do you feel?’ Does it really provide independent prognostic information for survival?
- Published in:
- 2009
- By:
- Publication type:
- Letter
Letter to the editor: Acute myeloid leukemia in a child affected by β-thalassemia major.
- Published in:
- American Journal of Hematology, 1988, v. 29, n. 2, p. 124, doi. 10.1002/ajh.2830290214
- By:
- Publication type:
- Article
Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 442, doi. 10.1016/j.clml.2022.01.009
- By:
- Publication type:
- Article
ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia: (ALL): PhALLCON Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S269, doi. 10.1016/S2152-2650(21)01653-0
- By:
- Publication type:
- Article
Poster: ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S209, doi. 10.1016/S2152-2650(21)01309-4
- By:
- Publication type:
- Article
Ponatinib vs Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) ALL: PhALLCON Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S194, doi. 10.1016/j.clml.2019.07.041
- By:
- Publication type:
- Article
Generation of a Quantitative Real Time-Polymerase Chain (Q-PCR) Assay to Identify BCR/ABL1-like ALL Cases.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S5, doi. 10.1016/j.clml.2016.07.008
- By:
- Publication type:
- Article
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 2, p. 141, doi. 10.1007/s12185-020-02920-y
- By:
- Publication type:
- Article
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 749, doi. 10.1002/ajh.25795
- By:
- Publication type:
- Article
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 993, doi. 10.1002/ajh.22161
- By:
- Publication type:
- Article
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 205, doi. 10.1111/j.1365-2141.2011.08940.x
- By:
- Publication type:
- Article
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 564, doi. 10.1111/j.1365-2141.2011.08593.x
- By:
- Publication type:
- Article
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 376, doi. 10.1111/j.1365-2141.2010.08095.x
- By:
- Publication type:
- Article
Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 1, p. 70, doi. 10.1111/j.1365-2141.2009.08056.x
- By:
- Publication type:
- Article
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 5, p. 681, doi. 10.1111/j.1365-2141.2008.07400.x
- By:
- Publication type:
- Article
Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients.
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 353, doi. 10.1002/jha2.873
- By:
- Publication type:
- Article
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article